Canada markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1,153.35-11.11 (-0.95%)
At close: 04:00PM EDT
1,157.00 +3.65 (+0.32%)
After hours: 07:49PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 127.14B
Enterprise Value 120.03B
Trailing P/E 30.54
Forward P/E 23.64
PEG Ratio (5 yr expected) 1.57
Price/Sales (ttm)9.78
Price/Book (mrq)4.51
Enterprise Value/Revenue 8.90
Enterprise Value/EBITDA 23.50

Trading Information

Stock Price History

Beta (5Y Monthly) 0.12
52-Week Change 339.88%
S&P500 52-Week Change 326.33%
52 Week High 31,211.20
52 Week Low 3769.19
50-Day Moving Average 31,121.21
200-Day Moving Average 3988.59

Share Statistics

Avg Vol (3 month) 3465.17k
Avg Vol (10 day) 3474.25k
Shares Outstanding 5108.42M
Implied Shares Outstanding 6110.23M
Float 8103.45M
% Held by Insiders 11.53%
% Held by Institutions 189.82%
Shares Short (Aug 30, 2024) 42.1M
Short Ratio (Aug 30, 2024) 44.46
Short % of Float (Aug 30, 2024) 42.01%
Short % of Shares Outstanding (Aug 30, 2024) 41.90%
Shares Short (prior month Jul 31, 2024) 42.01M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 32.04%
Operating Margin (ttm)30.83%

Management Effectiveness

Return on Assets (ttm)7.62%
Return on Equity (ttm)16.55%

Income Statement

Revenue (ttm)13.49B
Revenue Per Share (ttm)125.83
Quarterly Revenue Growth (yoy)12.30%
Gross Profit (ttm)N/A
EBITDA 4.52B
Net Income Avi to Common (ttm)4.32B
Diluted EPS (ttm)37.71
Quarterly Earnings Growth (yoy)47.90%

Balance Sheet

Total Cash (mrq)9.81B
Total Cash Per Share (mrq)90.88
Total Debt (mrq)2.7B
Total Debt/Equity (mrq)9.58%
Current Ratio (mrq)5.44
Book Value Per Share (mrq)261.41

Cash Flow Statement

Operating Cash Flow (ttm)4.07B
Levered Free Cash Flow (ttm)2.09B